Antidiabetic Effects of a Chinese Herbal Medicinal Compound Sangguayin Preparation via PI3KAkt Signaling Pathway in dbdb Mice

Abstract EN

Sangguayin (SGY), comprising four types of Chinese herbs, can be used as both food and medicine and has been clinically used to treat type 2 diabetes mellitus (T2DM) for a long time.

Our previous study demonstrated the antidiabetic effect of SGY in experimental T2DM rats fed with a high-fat diet and treated with a low dose of streptozotocin.

However, its mechanism of action is questionable.

In this study, we refined the traditional SGY decoction and investigated its antidiabetic activity in db/db mice.

We evaluated the possible molecular mechanism using skeletal muscle tissues.

The results show that the treatment with SGY preparation resulted in a decrease in the blood glucose, glycated serum protein, and blood lipid levels and an improvement in the glucose tolerance as well as insulin resistance.

In addition, SGY preparation remarkably upregulated the expression of insulin receptor, insulin receptor substrate-1, phosphoinositide 3 kinase (PI3K), protein kinase B (Akt), and glucose transporter type 4 (GLUT4).

Thus, SGY preparation is an effective agent for the treatment of T2DM, and its molecular mechanism may be related to the regulation of PI3K/Akt signaling in the skeletal muscle.